Preventing 
cardiovascular

events with research

Personalised medicine for coronary heart disease

EU-funded CoroPrevention project aims to discover long-term behaviour changes and lifestyle improvements as well as medications needed by individual patients with coronary heart disease to prevent another cardiovascular event.

The project’s objective is to significantly reduce premature deaths and severe disabilities in patients with coronary heart disease in Europe. The CoroPrevention project studies 12,000 patients from six EU countries.

Read more

Cardiovascular diseases cost €210 billion a year

Cardiovascular disease (CVD) accounts for 47% of deaths in women and 39% of deaths in men worldwide. CVDs cost the EU more than €210 billion a year, a sum expected to escalate with an ageing population and the cost of novel therapies.

We estimate that the CoroPrevention programme will reduce the cardiovascular event rate by 25% in high-risk patients – with annual savings of tens of billions of euros to the EU.

Read more

Latest news & events

Apr 29, 2020, 11:50 AM
Using the Onnikka weight management program to meet European clinical practice guidelines
At the beginning of 2020, the EU kicked off the international CoroPrevention research project, which concentrates on the…
Read more
Feb 20, 2020, 2:53 PM
CoroPrevention Kick-off meeting
19th-20th February 2020 in Nice
Read more
Feb 19, 2020, 3:58 PM
Europe to personalise prevention of second heart attacks
A major EU-funded project to personalise prevention of second heart attacks is being launched today by the European…
Read more